In a molecular docking experiment between an epitope vaccine and the viral protein-binding TLR4, the lowest energy score of 986.5 indicates the vaccine would have an infection-inhibitory function and would be tightly bound to the TLR4 receptor [86]. This evidence concerns the gene TLR4 and infection.